HCPCS Code Q4123: Alloskin RT billing guide

Found our content helpful?

Key takeaways

HCPCS Code Q4123 describes Alloskin RT, a skin substitute billed per square centimeter as an add-on to a primary CPT application code

Wound site and size decide the primary code, so 15271, 15273 and 15275 are not interchangeable

Medicare pays a flat national rate of $127.14 per square centimeter for Q4123 in 2026, set by the CY2026 Physician Fee Schedule final rule

The high-cost and low-cost tiers are retired, and CMS now pays these products as incident-to supplies rather than biologicals

Most MACs withdrew their skin substitute LCDs in December 2025, so coverage is decided case by case outside the Novitas, CGS, and First Coast jurisdictions

Discarded product is no longer payable, so bill only the square centimeters applied and leave the JW modifier off Q4123 claims

HCPCS Code Q4123 bills Alloskin RT, a processed human dermal allograft, per square centimeter of wound treated. Medicare pays a flat national rate of $127.14 per square centimeter for it in 2026.

It is an add-on product code, so every claim also carries a primary CPT application code chosen by wound site and wound size.

Two 2026 changes decide how that claim is built. CMS now pays skin substitutes as incident-to supplies rather than biologicals, which ended payment for discarded product. Most MACs also withdrew their skin substitute LCDs, so coverage now turns on the record you submit.

Most skin substitute billing errors start before the claim is built. Coders reach for a product Q-code without confirming the matching application code. Others skip the wound measurement, or miss a coverage requirement their own contractor still enforces.

HCPCS Code Q4123: Definition, product and billing classification

HCPCS Code Q4123 is the Level II code that describes Alloskin RT, per square centimeter. It sits in the HCPCS Q-code series as a skin substitute product code. The Centers for Medicare and Medicaid Services (CMS) maintains that series under the HCPCS Level II system.

As a product code, Q4123 identifies what was applied to the wound, not how it was applied. The “how” is captured by a separate primary CPT application code. Medicare pays the product itself at a flat national rate of $127.14 per square centimeter in 2026.

Alloskin RT is a human tissue allograft used on chronic and acute wounds. The per-square-centimeter billing unit means the claimed amount must match the documented wound surface area at the time of application.

2026 Medicare fee schedule for HCPCS Code Q4123

Medicare pays a flat national rate of $127.14 per square centimeter for Q4123 in 2026. That single figure replaced the average sales price calculation on January 1, 2026.

It applies in the physician office and in the hospital outpatient department alike, so the site of service no longer changes the product rate.

The change came from the CY2026 Physician Fee Schedule final rule, CMS-1832-F, as corrected on November 26, 2025. CMS reclassified most skin substitute products from separately payable biologicals to incident-to supplies.

The CY2026 OPPS and ASC final rule then adopted the same $127.14 per cm² rate. It sits under a new status indicator, S1, which signals separate payment on the outpatient side.

The arithmetic is now simple enough to do at the point of care. A 12 cm² wound treated with Alloskin RT bills 12 units of Q4123, which comes to $1,525.68 for the product at the national rate. The application CPT code is paid on its own line in addition to that amount.

CMS publishes $127.14 as a national figure. Run your own locality through the CMS Physician Fee Schedule lookup tool before you quote a number to a patient or a payer. Re-check it every January, because the rate is now set in the annual rule cycle rather than in quarterly ASP files.

What replaced the high-cost and low-cost classification

Nothing replaced it. CMS retired the high-cost and low-cost skin substitute split when the 2026 rules took effect.

Before that, OPPS sorted skin substitutes into a high-cost tier that received separate payment and a low-cost tier that was packaged into the application procedure. A product’s tier decided whether it earned its own line of payment at all.

Under the 2026 methodology, every product in scope receives the same per-cm² amount, so the old tier no longer changes anything on the claim.

Plenty of payer manuals, vendor sheets, and coder references still sort skin substitutes into high-cost and low-cost buckets. Treat any of that guidance as pre-2026 unless it names the $127.14 rate.

The methodology has already been tested in court and held. The CAMPs Initiative sued the Department of Health and Human Services over the flat rate.

A federal court in Texas dismissed that case in March 2026 on jurisdictional grounds. A second suit was dismissed on the same grounds in August 2026. The $127.14 rate remains in force for the 2026 payment year.

How to bill HCPCS Code Q4123: Add-on code requirements

Q4123 is an add-on code. It cannot stand alone on a claim. Every Q4123 line item must be paired with a primary CPT wound care application code on the same date of service. Submitting Q4123 without a companion CPT code is the single most common reason the code is denied.

Two variables pick the primary code. The first is where the wound sits, and the second is its total surface area. Trunk, arm, and leg wounds run on one CPT family, while face, scalp, hand, and foot wounds run on another.

Within the trunk, arm, and leg family, wounds under 100 cm² are billed in 25 cm² increments. Wounds of 100 cm² or more are billed in 100 cm² increments. Face, scalp, hand, and foot wounds are billed in 25 cm² increments. Only the first code in each pair is a primary. The second is an add-on that never opens a claim.

The table below lists the application codes Q4123 pairs with. Confirm the pairing and any bundling edits against your MAC’s current billing article before you submit.

Billing sequence: List the primary application code as the first procedure. That is 15271 or 15273 for a trunk, arm, or leg wound, and 15275 for a face, scalp, hand, or foot wound. Q4123 follows on a separate line with the same date of service.

Codes 15272, 15274, and 15276 attach to their own primary and never open the claim. The number of Q4123 units must match the documented wound area in cm². The chart below sets the three pairings side by side.

Modifier requirements for Q4123 billing

Modifiers are required or conditionally required on Q4123 claims depending on the payer and billing scenario. The 2026 reclassification changed which ones apply, so a modifier habit carried over from 2025 is now a denial risk. Refer to your MAC’s current billing article for jurisdiction-specific rules.

Wastage is the rule that changed hardest. Medicare does not pay for discarded amounts of an incident-to supply under any circumstances.

If your team opens a 16 cm² sheet of Alloskin RT and applies 11 cm², you bill 11 units and absorb the remainder. Sizing the product to the wound before it comes out of the package is now a margin decision, not just good practice.

Medicare coverage and LCD requirements for Q4123

Most Medicare jurisdictions no longer have a published skin substitute LCD, so coverage for Q4123 is decided case by case against the reasonable-and-necessary standard. Three A/B MACs are the exception and still enforce active legacy policies.

Practices billing Q4123 should build medical billing compliance checks that confirm their own contractor’s current position before the date of service.

On December 24, 2025, CMS announced that the A/B MACs had withdrawn their unified skin substitute LCDs. Those LCDs covered grafts used in diabetic foot ulcers and venous leg ulcers.

They had been scheduled to take effect on January 1, 2026. Palmetto GBA’s draft LCD DL39806 and its companion billing article A59691 were withdrawn with them.

That withdrawal moved the ground under a lot of published wound care billing guidance. Palmetto GBA, which administers Jurisdictions J and M, currently has no skin substitute LCD at all. National Government Services, WPS, and Noridian are in the same position.

• Confirm your MAC jurisdiction first. Only Novitas, CGS, and First Coast publish a skin substitute LCD to follow. Everyone else reviews Q4123 claims one at a time.
• Case by case is not the same as automatic. Where no LCD exists, the claim still has to meet Medicare’s reasonable-and-necessary standard on the strength of the record alone.
• Map diagnosis codes deliberately. In a Novitas, CGS, or First Coast jurisdiction, bill Q4123 against a diagnosis that appears on that LCD’s covered list.
• Document wound chronicity every time. The retained LCDs require evidence that standard care failed, and reviewers in no-LCD jurisdictions look for the same history.
• Watch for replacement policies. CMS has signaled that revised skin substitute coverage rules may return, so re-check your contractor’s coverage page each quarter.

Prior authorization requirements for skin substitutes vary by payer and MAC. Some Medicare Advantage plans require pre-authorization even when traditional Medicare does not. Confirm authorization requirements with each payer individually before scheduling Q4123 application.

ICD-10 diagnosis codes commonly billed with Q4123

There is no longer a single national or unified list of covered diagnoses for skin substitutes. The withdrawn LCDs would have supplied one, and they are gone.

The codes below are the families that carry the clinical story most Q4123 claims rest on. They matter whether a reviewer checks them against an LCD or against the reasonable-and-necessary standard.

Code to the highest specificity the chart supports, and sequence the underlying condition before the ulcer code where ICD-10 guidelines require it. In the Novitas, CGS, and First Coast jurisdictions, check the selected code against that LCD’s covered list before the claim goes out.

Documentation requirements for HCPCS Code Q4123 claims

Incomplete documentation is the second most common reason skin substitute claims are denied after coding errors.

The per-square-centimeter unit structure of Q4123 means every claimed unit must trace back to a measurement recorded in the patient’s chart. Documentation failures come back as denial codes such as CO-50 and CO-97, and a complete chart prevents both.

• Wound size in cm²: Measure and record the wound’s length and width at the time of application. The documented surface area must equal or exceed the number of Q4123 units billed.
• Units applied versus units opened: Record both figures. Medicare pays only for the square centimeters placed on the wound, so the chart should show what was opened and what was used.
• Wound description and chronicity: Document wound type, duration, and prior treatment attempts. The retained LCDs require evidence that standard wound care failed, and case-by-case reviewers look for the same history.
• Product identification: Record the product name (Alloskin RT), lot number, expiration date, and quantity used. Some MACs require the manufacturer’s invoice or delivery documentation as a supporting record.
• Physician order: A documented physician order for the skin substitute application must be present in the record. Standing orders are not acceptable in most jurisdictions.
• Medical necessity statement: A brief clinical note should explain why the skin substitute was selected and what treatment history preceded the decision. Where no LCD applies, this note is the claim’s main defense.
• Date of application: The date recorded in the chart must match the date of service on the claim. Discrepancies trigger automatic review flags.

Build a documentation checklist into your wound care workflow that captures all seven elements above before the claim is built. Practices that review the chart at the point of care catch most issues before they reach the billing team.

Common billing errors and denial reasons for Q4123

Skin substitute claims fail more often than most wound care codes. They sit at the intersection of product coding, procedure coding, and medical necessity review. Each layer is its own denial risk. Categorize Q4123 denials separately from standard procedure denials so the pattern behind them stays visible.

• Missing or mismatched primary CPT code: Q4123 submitted on its own, or paired with a code that does not match the wound. Trunk, arm, and leg wounds take 15271 or 15273 by size, and face, scalp, hand, and foot wounds take 15275. Fix: build the claim with the correct application code first, then add Q4123.
• Unit mismatch: The number of Q4123 units billed does not match the documented wound area. Billing 10 units on a chart that records a 6 cm² wound triggers a medical review. Fix: bill the documented cm² applied, and nothing beyond it.
• Billing discarded product: Units claimed for material that was opened but never applied. Medicare stopped paying skin substitute wastage on January 1, 2026. Fix: bill only the square centimeters placed on the wound.
• Coverage assumed rather than verified: The claim goes out on the assumption that a skin substitute is covered. In Novitas, CGS, and First Coast jurisdictions the diagnosis has to sit on the LCD’s covered list. Fix: check your contractor’s current coverage page before scheduling the application.
• Outdated modifiers: Appending JW or JZ to a Q4123 line, or submitting GZ when an ABN is on file. Both generate payment integrity flags. Fix: drop the wastage modifiers and keep GA and GZ straight.
• Missing product documentation: Lot number, expiration date, or physician order absent from the record. MACs audit skin substitute claims at higher rates than most outpatient services. Fix: use a pre-service documentation checklist.
• Same-day procedure bundling: Q4123 billed on the same date as a debridement without modifier 59 where required. Some edits bundle the skin substitute into the debridement payment unless the distinctness of the service is flagged. Fix: confirm NCCI edits for your specific CPT-to-Q-code combination before submission.

Related skin substitute billing codes for wound care

HCPCS Code Q4123 is one of dozens of skin substitute Q-codes in the active CMS HCPCS catalog. Billers working in wound care settings will encounter these related codes regularly.

The table below lists the most commonly cross-referenced HCPCS and CPT codes. For a full listing, use the AAPC HCPCS code lookup or the NLM Clinical Tables API.

Never use Q4100 as a substitute for Q4123 when Alloskin RT is the product applied. Q4100 is a catch-all code for products that have no specific HCPCS code of their own.

Using it when a specific code exists is a coding inaccuracy that can trigger audit risk. Add a product-to-code verification step to the wound care workflow, matching the product used against the current HCPCS Q-code catalog before the claim is built.

How practice management software supports Q4123 billing

Wound care billing is high-volume and detail-intensive. A single missing lot number or a transposed wound measurement can turn a clean claim into a denial.

Practices cut that risk with faster, cleaner claims management. It builds code pairing validation and documentation requirements into the clinical workflow, rather than relying on coder memory at the back end.

Practice management software like Pabau supports practices billing skin substitute codes with a claims management workflow that connects documentation capture to claim submission.

When a wound care encounter is recorded, the platform can prompt for wound measurement, product details, and physician order confirmation before the encounter closes.

That means the documentation required to support HCPCS Code Q4123 is captured at the point of care, not reconstructed after a denial.

• Code library integration: HCPCS and CPT codes are searchable within the billing workflow, reducing manual entry errors on add-on code pairs.
• Documentation prompts: Configurable encounter templates can require wound measurement fields before an encounter is marked complete.
• Denial tracking: Denied Q4123 claims are flagged for review with denial reason codes attached, supporting faster appeals and root-cause analysis.
• Multi-payer support: Practices managing both Medicare and commercial payer claims for the same patients can track payer-specific rules in one system.

Practices running several wound care sites need one view of billing across locations. Centralizing it lets a manager see a pattern denial forming before it spreads across every site. Add-on code pairs reward systematic validation in the workflow over a manual check at each step.

Simplify wound care billing workflows

Pabau supports skin substitute billing with built-in documentation capture, code pairing validation, and claims management tools that reduce denials and streamline submission.

Book a demo

Conclusion

HCPCS Code Q4123 is a straightforward code with a narrow margin for error, and 2026 narrowed it further. The flat $127.14 per cm² rate removed the pricing guesswork.

It also ended payment for wastage and retired the modifiers most coders were used to appending. At the same time, the LCD withdrawal shifted coverage in most jurisdictions from a written rule to a judgment call on the record you submit.

That combination puts the weight on documentation. Practices that capture wound measurement, product detail, and treatment history inside the clinical encounter clear both hurdles before the claim is built.

The practices that struggle are the ones still reconstructing that record after a denial arrives. To see how Pabau keeps wound care documentation and claim submission on one record, book a demo with our team.

Continue your research

Looking for guidance on the claim submission process from start to finish? Our medical billing overview walks through each stage of the revenue cycle, from code assignment to payment posting.

Frequently asked questions

Coverage, wastage, and documentation questions